Tyrosinase (TYR) is a key
enzyme for
melanin production. We previously showed that
hinokitiol, a naturally occurring seven-membered ring
terpenoid, potently inhibits human TYR activity. Interestingly,
hinokitiol was recently reported to decrease expression of TYR and
microphthalmia-associated transcription factor (MITF), which is a main
transcription factor of the TYR gene, in murine
melanoma cells. However, the mechanisms by which
hinokitiol decreases the intracellular levels of TYR and MITF have not been fully elucidated. Here, we investigated the underlying mechanisms of the decreases using cultured human
melanoma cells. As a result,
hinokitiol treatment decreased TYR
protein level in a time- and dose-dependent manner in G361 human
melanoma cells, while
MITF protein level was decreased only at higher concentrations after 3 days treatment. Notably, the
mRNA levels of TYR and MITF were slightly increased by
hinokitiol treatment. Therefore, we focused on the degradation of TYR and MITF in endoplasmic reticulum (ER)-associated protein degradation (ERAD) pathway. Importantly, co-treatment of ERAD inhibitor with
hinokitiol restored the
protein levels of TYR and MITF to approximately 30% and 20% of total those in untreated control cells, respectively.
Hinokitiol affected the ER homeostasis as well as degradation of TYR and MITF in two human
melanoma cell lines, G361 and HT-144, but the changes of ER-stress markers under the
hinokitiol treatment were different in the two human
melanoma cell lines. Taken together, these observations indicate that
hinokitiol may induce ER stress and trigger the degradation of unfolded newly synthesizing TYR and MITF via the ERAD pathway.